Mind the Gap Services’ Post

FemTech, short for "Female Technology," was coined in 2016 to categorize an innovative sector using tech to address women's unique health needs. From fertility tracking apps to telehealth platforms for menopause, FemTech companies are gaining major traction in the healthcare landscape, ensuring that women's health gets the focus it deserves. 📊 Did you know? By some accounts, the global FemTech market is projected to grow to $60 billion by 2027. In our latest post, we explore the evolution of FemTech, its historical roots, and the impact it's having on women's health. From reproductive health to chronic disease management, learn how FemTech is shaping a more inclusive future in healthcare. 👉 Read the full article and let us know what you think. #WomenInTech #HealthcareInnovation #FemTech #WomensHealth #DigitalHealth #HealthEquity #InclusiveHealthcare

What is FemTech and where is it heading? Sage Revell, Life Sciences specialist and partner at Brown Rudnick LLP, answers these questions and more in her article in August's issue of Financier Worldwide Magazine. FemTech refers to software and services that use technology tailored towards women's health. The list of areas it covers includes fertility solutions, menstrual healthcare, cancer screenings and treatments, women’s sexual wellness, menopause and hormonal disorders. The article caught our eye because this is a space we're interested in, and have invested in through female welllness brand Feel - Wellness, Reimagined. One of Feel's products is Feel Menopause, designed to combat the many symptoms of menupause, such as hot flushes, night sweats, and fatigue. The historical lack of funding in FemTech has meant lack of growth, but as Sage highlights in Catching the Herd of FemTech Unicorns, the tide is now turning and governments and investors alike are now backing the exciting innovations fueling this space. It’s certainly a space to watch!    Read the article in full below. #FemTech #WomensHealth #FemaleHealth #Menopause FemTech Lab

The FemTech (female technology) market has experienced remarkable growth since 2020, expected to continue through 2025. In 2020, the global FemTech market was valued at approximately $40.2 billion. By 2025, it is projected to reach $75.1 billion, representing a compound annual growth rate (CAGR) of 13.3% (FemTech Analytics). The significant growth of the FemTech market can be attributed to various factors, including the increasing digitalization of healthcare, heightened health awareness among women, and substantial investments from venture capitalists and angel investors. The FemTech market includes reproductive health, pregnancy and nursing care, menstrual health, pelvic and uterine healthcare, and general wellness (Global Market Insights Inc.). Regionally, North America leads the FemTech market, hosting about 55% of the total number of FemTech companies. Europe follows with 25%, while Asia holds approximately 8% (FemTech Analytics). The United States, in particular, is the dominant player, accounting for nearly half of all FemTech companies worldwide (FemTech Analytics). Key subsectors within FemTech include pregnancy and nursing, which accounts for 21% of the market, followed by reproductive health and contraception at 17%. Menstrual health and general healthcare each comprise 14% of the market (FemTech Analytics). The adoption of digital health solutions and wearable devices has significantly contributed to market growth, especially in areas such as period tracking, fertility, and pregnancy monitoring (Grand View Research) (Global Market Insights Inc.). Source: (1) Arizton Advisory & Intelligence; (2) IHS Markit PM; (3) World Bank #womenshealth #womenshealthmattters #tech #femtech #healthtech #womenintech 

🚀 Excited to share insights from our panel discussion at Perspektywy Women in Tech on "FEMTECH - Technology in the Service of Women"! 🌟 Delving into #WomensHealth, we explored how technology can foster inclusivity and support women. Here are the key takeaways: 👉 Beyond Reproductive Health: Femtech is not just about reproductive health. It started with a focus on fertility but has evolved to address a broad range of women's health needs, from mental health to chronic conditions. 👉 Current and Future Needs: While femtech addresses many needs like menstrual health, pregnancy, and menopause, there are still areas that require more attention, such as education and combating cyberviolence. 👉 Gender-Specific Health Considerations: It's crucial for women to consider gender-specific health conditions (menstruation and menopause, endometriosis, PMS, breast and cervical cancer...) Tailored health care can significantly improve wellbeing and productivity at work, as well. 👉 Role of Bots: Bots (like Victoria chatbot) can be more than just technical support. They have the potential to independently support women's health and emotional issues, offering immediate assistance and comfort. 👉 AI in Femtech: AI-powered apps offer incredible opportunities for personalized health care but also pose risks like data privacy concerns. Balancing innovation with safety is key. 👉 Health prevention, regular screenings, and addressing women's specific health needs are vital for enhancing workplace wellbeing. Technology can be a powerful ally in this journey, fostering a more inclusive and supportive environment for women. 👉 I'm happy to mention that Sophia Health is already contributing in this area by providing personalized healthcare solutions for women, ensuring they receive care tailored to their unique needs. 🚺 A huge congratulations to Bianka Siwinska, PhD for organizing this incredibly successful event with 10,000 participants! Thank you to my fantastic co-panelists: Martina T., and Joanna Gzyra-Iskandar for their valuable insights and to Karolina Wasielewska for great moderation! 🙌 #Femtech #WomenInTech #HealthTech #WomenAtWork #WorkplaceWellbeing #Perspektywy2024 Sophia Health, Monika Lukasiewicz, MD, PhD

Given femtech has about 50% of the global population as target customers – as well as studies showing women are likely to spend 29% more per capita on healthcare needs than men, while also being 75% more likely to use digital tools for health-related information – it is perhaps not surprising it’s predicted by experts to be the “next big phenomenon”. On the surface, the signs support the hype. While still a small segment of the healthtech market, femtech is growing exponentially: currently valued at $28bn (£22.3bn), up from $500m a decade ago, the global femtech market is estimated to reach $60bn by 2027. But inside the industry, things are far from rosy. Investment in femtech stands at just 1-2% of total health technology funding. And between 2011 and 2021, only 4% of new medical technology drugs relating to female-specific health conditions were approved in the US. Even once femtech companies have secured funding and their product is ready for the market, they face challenges that companies targeting men’s health do not. https://buff.ly/4fePjUr #womenshealth #femtech #healthtech #digitalhealth #healthcare #healthcareinnovation #startups #innovation #health #medtech #healthcareresearch #femalehealth #genderhealthgap #reproductivehealth #venturecapital #vc #funding #investment #grants #maternalhealth #periods #menstruation #sexualhealth #sextech #menopause #fertility #pregnancy #postpartum #eggfreezing #IVF #healthequity #pelvicfloor #pelvicfloorhealth #hormonehealth

We read an article in The Guardian that hits close to home. It talks about the huge disadvantage women behind the FemTech phenomenon face—something we at GLORIAH have experienced firsthand. When 50% of the population is impacted by women’s health issues, it’s staggering that less than 4% of healthcare R&D is focused on women-specific conditions like menopause. This lack of attention isn’t just frustrating, it’s limiting the progress we can make in improving women’s lives. At GLORIAH, we’re working to break the silence around menopause and women’s health, but the truth is, it’s an uphill battle. Especially in male-dominated spaces where the conversation often doesn’t even get started. Securing funding? Building partnerships? These tasks are made harder by the fact that only 2.3% of venture capital funding goes to women-led companies. We’ve felt the sting of that statistic in more ways than one. Why? In large part, it’s a lack of education. Menopause and women’s health aren’t seen as priorities by those who aren’t personally affected. It’s too often dismissed, underfunded, and misunderstood. But that’s why we keep pushing. Because women’s health is everyone’s health, and the conversation is long overdue. Our mission is simple: to make menopause mainstream, to get the support and solutions we deserve, and to drive the innovation that’s been too long ignored. The need for FemTech is real. The change we can bring is immense. It’s time the world takes notice—and we won’t stop until it does. Here’s to demanding better. 💪 Shout out to Mo Carrier, Tess Isabelle Cosad, Farah K., Clio Wood, Valentina Milanova 🇺🇦, Rachel Bartholomew, Tara Attfield-Tomes - so refreshing to see this brought to mainstream conversation! #femtech #womenshealth https://lnkd.in/e3QuQPQb

🔬 What does it really take to close the women's health research gap? Join us on April 28 for a fireside chat with Daye's Valentina Milanova 🇺🇦 and adyn's Elizabeth Ruzzo, PhD., pioneering founders in the femhealth space, who join Femtech Insider's Kathrin Folkendt to discuss how they're working towards bridging the gender data gap while improving care for more than half of the world's population. 💫 A few of the topics they'll discuss: ➡ Closing gender and race research gaps in medical studies ➡ The impact of personalized healthcare solutions on mental and physical well-being ➡ Experiences of female founders in the health sector ➡ Criteria for evaluating healthcare products and services ➡ Addressing myths in women’s health: periods, birth control, sexual health, and vaginal care The webinar is FREE to attend! Grab a ticket and save your seat today! 👇 #femtech #femhealth #womenshealthinnovation #womenshealth #health #healthcare #healthcareinnovation #precisionhealth #genderdatagap #genderhealthgap #womenshealthresearch #startup #scaleup #entrepreneurship #healthtech #biotech #digitalhealth #event #webinar #firesidechat

🔬🌍 At BioTalent, our mission is to address the talent shortage within Life Sciences by leveraging specialist communities while promoting diversity and equity for all. Women may live longer than men (4.5 years longer on average), but they endure 25% more time in poor health. Inequities in efficacy and care delivery of the top five interventions contribute to 57 percent of the women’s health gap. There are an increasing number of global healthtech companies making significant strides in reducing the inequality in women's health by leveraging innovative technologies and tailored solutions. Here are some examples: Flo Health Inc. - This app helps women manage their menstrual cycles and overall reproductive health. It provides personalized insights and tracks various health metrics to improve women's health management (HealthcareTech). LunaJoy Health - Offering holistic mental health counseling and therapy online, LunaJoy focuses on mental health issues specific to women, such as antepartum and postpartum depression and premenstrual dysphoric disorder(HealthcareTech). Juno Bio - This company provides at-home vaginal microbiome tests, helping women understand their vaginal health better and manage conditions more effectively (HealthcareTech). Irth - An app where women of color can review doctors and hospitals based on their prenatal, birthing, postpartum, and pediatric experiences, aiming to reduce disparities in care for women of color (HealthcareTech). NUA SURGICAL - An Irish femtech startup that developed the SteriCISION C-section Retractor, which improves access and visibility during caesarean deliveries, enhancing the safety and outcomes of these procedures(HealthcareTech). Oova - In collaboration with Mount Sinai Hospital, Oova provides an at-home hormone test paired with a smartphone app to offer personalized fertility plans, addressing fertility challenges faced by many women(HealthcareTech). These companies are part of a growing femtech sector, projected to reach $50 billion by 2025, dedicated to addressing unmet needs in women's health through technological innovation. BioTalent have a dedicated healthtech team who are solely focused on supporting this crucial market sector and we have a new community in development to support people who are passionate about reducing health inequality. Watch this space and get in contact to find out more or be an early member of the community. Perrin Joel Eve Coxeter Natalie Wattenbach Sophie H. Sarah Pawar Leah James Nicholas Boyle Dan Jeffery Melody Lam Craig Brown #WomensHealth #HealthEquity #BioTalent #HealthcareInnovation

FemTech innovations are reshaping the landscape of healthcare, empowering women to take control of their well-being like never before. I want to share and spotlight UriCap Female by TillaCare Ltd. as an example of remarkable FemTech excellence. UriCap Female is an innovative (patented) non-digital consumer device that exemplifies the core criteria of FemTech innovation by addressing crucial aspects of women's health in a revolutionary manner. 1️⃣ 𝐈𝐦𝐩𝐫𝐨𝐯𝐢𝐧𝐠 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐞𝐬: UriCap Female contributes to advancing diagnostics, addressing critical needs facilitating faster, accurate UTI diagnosis within added risk. Like clinical diagnostics companies focusing on endometriosis and preterm birth, TillaCare represents a significant stride towards better healthcare outcomes for UTI diagnosis in women. 2️⃣ 𝐀𝐝𝐝𝐫𝐞𝐬𝐬𝐢𝐧𝐠 𝐒𝐭𝐢𝐠𝐦𝐚𝐭𝐢𝐳𝐞𝐝 𝐀𝐫𝐞𝐚𝐬: TillaCare is disrupting healthcare, boldly confronting the stigmatized topic of pelvic health and urinary incontinence via UriCap Female. By openly addressing urinary incontinence, we join the ranks of companies breaking taboos around menstrual health, sexual health, and menopause. 3️⃣ 𝐄𝐧𝐚𝐛𝐥𝐢𝐧𝐠 𝐒𝐞𝐥𝐟-𝐂𝐚𝐫𝐞: With UriCap Female, women can now take greater charge of their urinary health with confidence. Similar to other FemTech solutions like trackers and at-home diagnostics, UriCap Female empowers women to manage their pelvic and UI proactively at home or in a clinical setting. 4️⃣ 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐢𝐧𝐠 𝐂𝐮𝐥𝐭𝐮𝐫𝐚𝐥𝐥𝐲 𝐒𝐞𝐧𝐬𝐢𝐭𝐢𝐯𝐞 𝐂𝐚𝐫𝐞: The impact of UriCap Female extends beyond borders, offering the only natural fit external female cather solutions for women worldwide. Just as other FemTech ventures cater to diverse populations, UriCap ensures that women from all walks of life receive the incontinence care solution they deserve. FemTech innovations like UriCap Female are the future - 𝘸𝘩𝘦𝘳𝘦 𝘸𝘰𝘮𝘦𝘯'𝘴 𝘩𝘦𝘢𝘭𝘵𝘩 𝘪𝘴 𝘱𝘳𝘪𝘰𝘳𝘪𝘵𝘪𝘻𝘦𝘥, 𝘢𝘤𝘤𝘦𝘴𝘴𝘪𝘣𝘭𝘦, 𝘢𝘯𝘥 𝘦𝘮𝘱𝘰𝘸𝘦𝘳𝘦𝘥. Join me in championing innovation that transforms lives and revolutionizes healthcare for all. Start by spreading awareness about FemTech innovations like UriCap Female. 𝑺𝒉𝒂𝒓𝒆 𝒕𝒉𝒊𝒔 𝒑𝒐𝒔𝒕 𝒘𝒊𝒕𝒉 𝒚𝒐𝒖𝒓 𝒏𝒆𝒕𝒘𝒐𝒓𝒌! Reach out to me directly if you are ready to adopt in your clinical practice, resell, or promote UriCap Female. #FemTech #HealthcareInnovation #EmpoweringWomen #uricap #nursesonlinkedin #WomenInHealthcare #InnovationInHealthcare #MedicalInnovation #HealthcareRevolution